References
- Gayle S, Landrette S, Beeharry N. et al., Blood. 2017;129(13):1768–1778.
- Polito VA, Li H, Martini-Stoica H. et al., EMBO Mol Med. 2014;6(9):1142–1160.
- Xiao Q, Yan P, Ma X. et al., J Neurosc. 2014;34(29):9607–9620
- Decressac M, Mattsson B, Weikop P, et al. PNAS. 2013;110(19):E1817–E1826.
- Shi Y, Lin S, Staats KA. et al. Nature Med. 2018;24(3):313–325.
- Hung ST, Linares GR, Chang WH. et al. Cell. 2023;2023;186(4):786–802.e28.
- Walker AK, Spiller KJ, Ge G. et al. Acta Neurophathol. 2015;130(5):643–660.
References
- Nishimoto Y, Nakagawa S, Hirose T, et al. Mol Brain. 2013;6:31
- Shelkovnikova TA, Kukharsky MS, An H, et al. Mol Neurodegen. 2018;13(1):30.
Reference
- Luan W, Wright AL, Brown-Wright H, Le S, San Gil R, Madrid San Martin L, Ling K, Jafar-Nejad P, Rigo F, Walker AK. Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD. Mol Psychiat. 2023.
References
- Cohen-Adad J, El Mendili MM, Morizot-Koutlidis R. et al. ALS-FTD. 2012;14(1):30–38.
- Branco LM, De Albuquerque M, De Andarade HM. et al. ALS-FTD. 2013;15(1-2):93--97.
- El Mendili M-M, Cohen-Adad J, Pelegrini-Isaac M. et al. PLOS One. 2014;9(4):e95516.
- Cathcart SJ, Appel SH, Peterson LE. et al. J Neuropathol Exp Neurol. 2021;80(8):754–763.
References
- Krug L, Chatterjee N, Borges-Monroy, et al. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. 2017;13(3):e1006635.
References
- Neumann M, Sampathu DM, Kwong LK, et al. Science. 2006;314(5796):130–3.
- Basso M, Pozzi S, Tortarolo M, et al. J Biol Chem. 2013;288(22):15699–711.
- Yamanaka K, Chun SJ, Boillee S, et al. Nat Neurosci. 2008;11(3):251–3.
References
- Neumann M, Bentmann E, Dormann D. et al. Brain. 2011;134:2595–609.
- Humphrey J, Birsa N, Milioto C. et al. Nucleic Acids Res. 2020; 48:6889–05.
References
- Blacher E, Bashiardes S, Shapiro H. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474–480
- Burberry, A, Wells MF, Limone F. et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582(7810):89–94.
- Cox LM, Calcagno N, Gauthier C. et al. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome. 2022;10(1):47.
References
- Liguori F, Amadio S, Volonté C. Where and why modeling amyotrophic lateral sclerosis. Int J Mol Sci. 2021;22(8):3977.
- Liguori F, Amadio S, Volonté C. Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers. Cell Mol Life Sci. 2021;78(17–18):6143–60.
- Watson MR, Lagow RD, Xu K et al. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem. 2008;283(36):24972–81.
References
- Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Berg ZS, van den LH. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:1–17.
- Merrilees J, Klapper J, Murphy J, Lomen-Hoerth C, and Miller BL. Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:298–302.
- Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, and Van Den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012;124,339–52.
- Peters OM, Ghasemi M, Brown RH, Jr. Emerging mechanisms of molecular pathology in ALS find the latest version: emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125:1767–79.
- McGown A, Pamela D, Shaw J, Ramesh T. ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis. Mol Neurodegener. 2016;56:3–11.
- Ramesh T, Lyon AN, Pineda RH, Wang C, Janssen PML, Canan BD, Burghes AHM, Beattie CE. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech. 2010;3:652–62.
- Abduljabbar O. A novel developing neurotherapeutics in ALS. Thesis (embargo). University of Sheffield; 2020: 1–220.
References
- Dupuis L, Loeffler JP. Curr Opin Pharmacol. 2009;9(3):341–6.
- Fischer LR, Culver DG, Tennant P. et al. Exp Neurol. 2004;185(2):232–40.
- Arbour D, Tremblay E, Martineau E. et al. J Neurosci. 2015;35(2):688–706.
- Martineau É, Arbour D, Vallee J. et al. J Neurosci. 2020;40(40):7759–77.
- Perez‐Gonzalez AP, Provost F, Rousse I et al. Glia. 2022;70(9):1605–29.
- Ahmadi M, Liu JX, Brannstrom T. et al. Invest Ophthalmol Vis Sci. 2010;51(7):3494.
- Sharma R. Arch Neurol. 2011;68(7):857.
- Pedrosa Domellöf F. (2020) The Extraocular Muscles Are Selectively Spared in ALS. Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges. IntechOpen. Available at: http://dx.doi.org/10.5772/intechopen.89504.
Reference
- Johnson J, Pioro E, Boehringer A, et al Nat Neurosci. 2014;17:639–743.
References
- Fischer LR, Culver LR, Tennant P. et al. Amyotrophic lateral sclerosisis a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232–40.
- Dadon-Nachum M, Melamed E, Offen D. et al. The “dying-back” phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470–7.
- Martineau È, Di Polo A, Vande Velde C. et al. Dynamic neuromuscular remodelling precedes motor-unit loss in a mouse model of ALS. Elife. 2018;7:e41973.
- Duchen LW, Gomez S, Queiroz LS. et al. The neuromuscular junction of the mouse after black widow spider venom. J Physiol. 1981;316:279–91
- Duregotti E, Negro S, Scorzeto M. et al. Mitochondrial alarmins released by degenerating motor axon terminals activate perisynaptic Schwann cells. Proc Natl Acad Sci USA. 2015;112(5):E497–505.
- Negro S, Lessi F, Duregotti E. et al. CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals. EMBO Mol Med. 2017;9:1000–1010
References
- Hou Z, Wydorski PM, Perez VA, et al. Nat Commun. 2021;12:5338.
- Farhan SMK, Howrigan DP, Abbott LE, et al. Nat Neurosci. 2019;22:1966–74.
- Hintermayer MA, Volkening K, Moszczynski A, et al. J Neurochem. 2020;155:313–26.
Reference
- Walker AK, Spiller KJ, Ge G, et al. Acta Neuropathol. 2015;130:643–60.